What is ENVB's earnings growth forecast for 2025-2025?
(NASDAQ: ENVB) Enveric Biosciences's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 5.14%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 15.23%.
Enveric Biosciences's earnings in 2025 is -$9,942,825.
In 2025, ENVB is forecast to generate -$41,877,064 in earnings, with the lowest earnings forecast at -$41,877,064 and the highest earnings forecast at -$41,877,064.
What is ENVB's forecast return on equity (ROE) for 2025-2028?
(NASDAQ: ENVB) forecast ROE is -534.88%, which is considered weak.
What is ENVB's Earnings Per Share (EPS) forecast for 2025-2025?
(NASDAQ: ENVB) Enveric Biosciences's current Earnings Per Share (EPS) is -$10.58. In 2025, ENVB's EPS is forecast to hit -$12.90 (min: -$12.90, max: -$12.90).
What is ENVB's forecast return on assets (ROA) for 2025-2028?
(NASDAQ: ENVB) forecast ROA is -329.33%, which is lower than the forecast US Biotechnology industry average of 47.39%.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.